与乳腺癌相关的二次淋巴的介质干细胞治疗 (综述)
Shunxin Han1,2, Junrong Cai1, Yuteng Zhang1
1Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Molecular and clinical oncology
|July 2, 2025
概括
介质细胞干细胞 (MSC) 疗法在乳腺癌后治疗二次淋巴方面表现有前途. 这种再生方法可以改善淋巴功能并减少胀,尽管需要更多的临床研究.
科学领域:
- 再生医学是一种再生医学.
- 在瘤学瘤学.
- 血管生物学 血管生物学
背景情况:
- 二次淋巴是乳腺癌治疗后的常见并发症,影响15-30%的幸存者.
- 目前治疗乳腺癌相关淋巴 (BCRL) 的疗法效果有限,缺乏确定的治愈方法.
- 干细胞治疗,特别是介质干细胞 (MSCs),是一个有前途的再生方法.
研究的目的:
- 审查二次淋巴的发病机制.
- 探索BCRL的干细胞治疗的进展.
- 分析当前的挑战,并指导未来的研究,以MSC为基础的BCRL治疗.
主要方法:
- 在动物淋巴瘤模型中进行的临床前研究的综述.
- 对用于淋巴的干细胞治疗现有临床数据的分析.
- 研究MSCs在调节炎症和纤维化的机制.
主要成果:
- 在临床前模型中,MSC疗法通过促进淋巴血管生成和减少纤维化而显示出潜力.
- 有证据表明,MSC可以再生淋巴网络并改善血管状况,缓解四肢不对称等症状.
- MSC治疗提供了一种潜在的机制来解决胀和改善生理淋巴功能.
结论:
- 介质细胞干细胞疗法对改善乳腺癌相关的淋巴有显著的前景.
- 为了建立标准化治疗方案,进一步进行大规模的临床研究和扩展后续检查至关重要.
- MSC治疗可能为淋巴提供一种再生解决方案,解决潜在的病理过程.
相关概念视频
01:19Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
01:21Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K